{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:01:20Z","timestamp":1780308080691,"version":"3.54.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"The Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["RS-2024-00332011"],"award-info":[{"award-number":["RS-2024-00332011"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Policy and Practice"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/20523211.2026.2676817","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:08:23Z","timestamp":1780304903000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Framework for identifying reference countries in drug safety evaluation: an application of the analytic hierarchy process"],"prefix":"10.1080","volume":"19","author":[{"given":"Gyeyoung","family":"Choi","sequence":"first","affiliation":[{"name":"Ewha Womans University","place":["Seoul, South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-8884","authenticated-orcid":false,"given":"Seungjin","family":"Bae","sequence":"additional","affiliation":[{"name":"Ewha Womans University","place":["Seoul, South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-019-0173-2"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10728-024-00505-y"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7177(93)90179-3"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2010"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/2168479016628573"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-024-01480-y"},{"key":"e_1_3_6_8_1","unstructured":"European Committee. (n.d.). International cooperation on pharmaceuticals. https:\/\/health.ec.europa.eu\/medicinal-products\/international-cooperation-pharmaceuticals_en"},{"key":"e_1_3_6_9_1","unstructured":"European Medicines Agency. (2004). ICH E2E Pharmacovigilance planning (Pvp) - Scientific guideline https:\/\/www.ema.europa.eu\/en\/ich-e2e-pharmacovigilance-planning-pvp-scientific-guideline"},{"key":"e_1_3_6_10_1","unstructured":"European Medicines Agency. (2014). ICH E2C (R2) Periodic benefit-risk evaluation report - Scientific guideline https:\/\/www.ema.europa.eu\/en\/ich-e2c-r2-periodic-benefit-risk-evaluation-report-scientific-guideline"},{"key":"e_1_3_6_11_1","unstructured":"EUROSTAT. (2024 April). International trade in medicinal and pharmaceutical products. https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=International_trade_in_medicinal_and_pharmaceutical_products"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-022-00415-y"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-025-01537-6"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_89_17"},{"key":"e_1_3_6_15_1","unstructured":"Health Insurance Review and Assessment Service. (2023). 2022 Statistics for drug product circulation information."},{"issue":"11","key":"e_1_3_6_16_1","first-page":"14336","article-title":"Review of the main developments in the Analytic Hierarchy Process","volume":"36","author":"Ishizaka A.","year":"2009","unstructured":"Ishizaka, A., & Labib, A. (2009). Review of the main developments in the Analytic Hierarchy Process. Expert Systems with Applications, 36(11), 14336\u201314345.","journal-title":"Expert Systems with Applications"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy11010010"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15193"},{"key":"e_1_3_6_19_1","unstructured":"Korea Law Information Center. (2023 December 5). Bioethics and Safety Act. https:\/\/www.law.go.kr\/%EB%B2%95%EB%A0%B9\/%EC%83%9D%EB%AA%85%EC%9C%A4%EB%A6%AC%EB%B0%8F%EC%95%88%EC%A0%84%EC%97%90%EA%B4%80%ED%95%9C%EB%B2%95%EB%A5%A0%EC%8B%9C%ED%96%89%EA%B7%9C%EC%B9%99"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2015.1053391"},{"key":"e_1_3_6_21_1","first-page":"1","article-title":"Leveraging real-world data in safety signal assessment","author":"Patadia V.","year":"2024","unstructured":"Patadia, V., Manlik, K., Gipson, G., Willis, J. C., Namuyinga, R., McDermott, R., Shaw, A., Miller, M. K., Asubonteng, J., & Golchin, N. (2024). Leveraging real-world data in safety signal assessment. Therapeutic innovation & regulatory science, 1\u20139.","journal-title":"Therapeutic innovation & regulatory science"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-01008-0"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1109\/TEM.1983.6448606"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0377-2217(90)90057-I"},{"key":"e_1_3_6_25_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-4939-3094-4_10","volume-title":"Multiple criteria decision analysis: State of the art surveys","author":"Saaty T. L.","year":"2016","unstructured":"Saaty, T. L. (2016). The analytic hierarchy and analytic network processes for the measurement of intangible criteria and for decision-making. In S. Greco, M. Ehrgott, & J. R. FigueiraMultiple criteria decision analysis: State of the art surveys (pp. 363\u2013419). Springer."},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpe.2012.03.036"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10479-021-04432-2"},{"key":"e_1_3_6_28_1","unstructured":"Therapeutic Goods Administration. (2024 October 1). Using assessments from comparable overseas regulators (CORs) for prescription medicines. https:\/\/www.tga.gov.au\/resources\/guidance\/using-assessments-comparable-overseas-regulators-cors-prescription-medicines"},{"key":"e_1_3_6_29_1","unstructured":"U.S. Food and Drug Administration. (2024 November 8). Questions and answers on FDA's adverse event reporting system (FAERS). https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers."},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0377-2217(90)90056-H"},{"key":"e_1_3_6_31_1","volume-title":"MCDM methods analysis: Advantages","author":"Velasquez M.","year":"2013","unstructured":"Velasquez, M., & Hester, P. T. (2013). MCDM methods analysis: Advantages. Disadvantages & Applications."},{"key":"e_1_3_6_32_1","first-page":"1","article-title":"Artificial intelligence","author":"Warner J.","year":"2025","unstructured":"Warner, J., Prada Jardim, A., & Albera, C. (2025). Artificial intelligence. Applications in Pharmacovigilance Signal Management. Pharmaceutical Medicine, 1\u201316.","journal-title":"Applications in Pharmacovigilance Signal Management. Pharmaceutical Medicine"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2026.2676817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:08:28Z","timestamp":1780304908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20523211.2026.2676817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/20523211.2026.2676817"],"URL":"https:\/\/doi.org\/10.1080\/20523211.2026.2676817","relation":{},"ISSN":["2052-3211"],"issn-type":[{"value":"2052-3211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2676817"}}